首页> 美国卫生研究院文献>The Journal of Physiology >Cytoskeletal disrupting agents prevent calmodulin kinase IQ domain and voltage-dependent facilitation of L-type Ca2+ channels
【2h】

Cytoskeletal disrupting agents prevent calmodulin kinase IQ domain and voltage-dependent facilitation of L-type Ca2+ channels

机译:细胞骨架破坏剂阻止钙调蛋白激酶IQ域和L型Ca2 +通道的电压依赖性促进

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

A calmodulin (CaM) binding ‘IQ’ domain on the L-type Ca2+ channel (LTCC) C terminus and calmodulin kinase II (CaMK) both signal increases in LTCC opening probability (Po) by shifting LTCCs into a gating mode (mode 2) with long openings through a process called facilitation. However, the mechanism whereby CaMK and the IQ domain are targeted to LTCCs is unknown. Endogenous CaMK is targeted to LTCCs in excised cell membrane patches because LTCC Po increased significantly in CaM-enriched (20 μm) bath solution and this effect was prevented by a specific CaMK inhibitory peptide, but not by an inactive control peptide. Pre-exposure of myocytes to the cytoskeletal disrupting agents nocodazole (microtubule specific) or cytochalasin D (microfilament specific) prevented the effects of CaM-dependent increases in Po of LTCCs in excised membrane patches. Neither cytochalasin D nor nocodazole altered the distribution of LTCC gating modes under basal conditions in on-cell mode or excised cell membrane patches, but each of these agents occluded the response of LTCCs to exogenous, constitutively active CaMK and to an IQ-mimetic peptide (IQmp). Cytochalasin D and nocodazole pretreatment also prevented LTCC facilitation that followed a cell membrane depolarizing prepulse. In contrast, cytochalasin D and nocodazole did not affect the increase in LTCC Po or prevent the shift to mode 2 gating in response to protein kinase A, indicating that cytoskeletal disruption specifically prevents prepulse, CaMK and IQ-dependent LTCC facilitation.
机译:钙调蛋白(CaM)结合L型Ca 2 + 通道(LTCC)C端和钙调蛋白激酶II(CaMK)上的“ IQ”结构域,两者信号均表明通过移位,LTCC开放概率(Po)增加LTCC通过称为促进的过程进入了具有较长开口的门控模式(模式2)。但是,CaMK和IQ域针对LTCC的机制尚不清楚。内源CaMK靶向切除的细胞膜贴片中的LTCC,因为在富含CaM的(20μm)浴液中LTCC Po显着增加,并且这种作用被特定的CaMK抑制肽阻止,但未被无效的对照肽阻止。心肌细胞预先暴露于细胞骨架破坏剂诺考达唑(微管特异)或细胞松弛素D(微丝特异)可防止CaM依赖性增加对切除的膜片中LTCC的Po的影响。细胞松弛素D和诺考达唑均不能改变基本条件下细胞模式或切除的细胞膜片在基础条件下LTCC门控模式的分布,但这些试剂均会阻止LTCC对外源性组成型活性CaMK和IQ拟肽的反应( IQmp)。细胞松弛素D和诺考达唑的预处理还阻止了细胞膜去极化预脉冲后的LTCC促进作用。相反,细胞松弛素D和诺考达唑不会影响LTCC Po的增加,也不会阻止对蛋白激酶A的响应而转变为2型门控,这表明细胞骨架的破坏特异性地阻止了前冲,CaMK和IQ依赖性的LTCC促进。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号